Progression-Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450) - De Ruysscher, D; Wanders, R; Hendriks, L (J Thorac Oncol, 2018)
et al.